Predicting locoregional recurrence in triple-negative breast cancer using novel molecular subtyping.

被引：0
|
作者：
Shao, Shali
Shi, Wei
Zhang, Li
Zhang, Qixian
Meng, Jin
Yang, Zhaozhi
Mei, Xin
Chen, Xingxing
Ma, Jinli
Mo, Miao
Shao, Zhimin
Zhang, Zhen
Guo, Xiaomao
Yu, XiaoLi
机构：
[1] Fudan Univ Shanghai Canc, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[3] Fudan Univ, Dept Breast Surg, Fudan Univ Shanghai Canc Ctr, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12549
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Triple-negative breast cancer: Clinical features and patterns of recurrence
    Dent, Rebecca
    Trudeau, Maureen
    Pritchard, Kathleen I.
    Hanna, Wedad M.
    Kahn, Harriet K.
    Sawka, Carol A.
    Lickley, Lavina A.
    Rawlinson, Ellen
    Sun, Ping
    Narod, Steven A.
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4429 - 4434
  • [32] Triple-Negative Breast Cancer: Pattern of Recurrence and Survival Outcomes
    Chintalapani, Shyny Reddy
    Bala, Stalin
    Konatam, Meher Lakshmi
    Gundeti, Sadashivudu
    Kuruva, Siva Prasad
    Hui, Monalisa
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (01) : 67 - 72
  • [33] Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
    Jezequel, Pascal
    Loussouarn, Delphine
    Guerin-Charbonnel, Catherine
    Campion, Loic
    Vanier, Antoine
    Gouraud, Wilfried
    Lasla, Hamza
    Guette, Catherine
    Valo, Isabelle
    Verriele, Veronique
    Campone, Mario
    BREAST CANCER RESEARCH, 2015, 17
  • [34] Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
    Pascal Jézéquel
    Delphine Loussouarn
    Catherine Guérin-Charbonnel
    Loïc Campion
    Antoine Vanier
    Wilfried Gouraud
    Hamza Lasla
    Catherine Guette
    Isabelle Valo
    Véronique Verrièle
    Mario Campone
    Breast Cancer Research, 17
  • [35] The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
    Weng, Lijuan
    Zhou, Jianliang
    Guo, Shenchao
    Xu, Nong
    Ma, Ruishuang
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [36] Novel molecular insights into pyroptosis in triple-negative breast cancer prognosis and immunotherapy
    Yu, Bin
    Luo, Junjie
    Yang, Yifei
    Zhen, Ke
    Shen, Binjie
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [37] Molecular characteristics of recurrent triple-negative breast cancer
    Tsai, Chung-Hsin
    Chiu, Jen-Hwey
    Yang, Chu-Wen
    Wang, Jir-You
    Tsai, Yi-Fang
    Tseng, Ling-Ming
    Chen, Wei-Shone
    Shyr, Yi-Ming
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 7326 - 7334
  • [38] Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
    Bradley A. Hancock
    Yu-Hsiang Chen
    Jeffrey P. Solzak
    Mufti N. Ahmad
    David C. Wedge
    Dumitru Brinza
    Charles Scafe
    James Veitch
    Rajesh Gottimukkala
    Walt Short
    Rutuja V. Atale
    Mircea Ivan
    Sunil S. Badve
    Bryan P. Schneider
    Xiongbin Lu
    Kathy D. Miller
    Milan Radovich
    Breast Cancer Research, 21
  • [39] Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
    Hancock, Bradley A.
    Chen, Yu-Hsiang
    Solzak, Jeffrey P.
    Ahmad, Mufti N.
    Wedge, David C.
    Brinza, Dumitru
    Scafe, Charles
    Veitch, James
    Gottimukkala, Rajesh
    Short, Walt
    Atale, Rutuja V.
    Ivan, Mircea
    Badve, Sunil S.
    Schneider, Bryan P.
    Lu, Xiongbin
    Miller, Kathy D.
    Radovich, Milan
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [40] Emerging Novel Therapeutics in Triple-Negative Breast Cancer
    Lyons, Tomas G.
    Traina, Tiffany A.
    BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 377 - 399
12345